2. Academic Validation
  3. Evaluation of DNA damage in Wistar rat tissues with hyperlipidemia induced by tyloxapol

Evaluation of DNA damage in Wistar rat tissues with hyperlipidemia induced by tyloxapol

  • Exp Mol Pathol. 2017 Aug;103(1):51-55. doi: 10.1016/j.yexmp.2017.06.009.
Joubert Aires de Sousa 1,  Patrícia Pereira 2,  Mariangela da Costa Allgayer 3,  Norma Possa Marroni 4,  Alexandre de Barros Falcão Ferraz 5,  Jaqueline Nascimento Picada 6
Affiliations

Affiliations

  • 1 Laboratory of Toxicological Genetics, Lutheran University of Brazil (ULBRA), Farroupilha Avenue, 8001, CEP 92425-900 Canoas, RS, Brazil.
  • 2 Laboratory of Neuropharmacology and Preclinical Toxicology, Federal University of Rio Grande do Sul (UFRGS), Sarmento Leite Street, 500/305, CEP 90050-170 Porto Alegre, RS, Brazil.
  • 3 Laboratory of Clinical Pathology, Veterinary Hospital, Lutheran University of Brazil (ULBRA), Farroupilha Avenue, 8001, CEP 92425-900 Canoas, RS, Brazil.
  • 4 Laboratory of Oxidative Stress and Antioxidants, Lutheran University of Brazil (ULBRA), Farroupilha Avenue, 8001, CEP 92425-900 Canoas, RS, Brazil.
  • 5 Laboratory of Pharmacognosis and Phytochemistry, Lutheran University of Brazil (ULBRA), Farroupilha Avenue, 8001, CEP 92425-900 Canoas, RS, Brazil.
  • 6 Laboratory of Toxicological Genetics, Lutheran University of Brazil (ULBRA), Farroupilha Avenue, 8001, CEP 92425-900 Canoas, RS, Brazil. Electronic address: ppgbiosaude@ulbra.br.
PMID: 28684216 DOI: 10.1016/j.yexmp.2017.06.009
Abstract

Hyperlipidemia is characterized by high levels of plasma triglycerides and LDL-cholesterol, accompanied by reduced HDL-cholesterol levels, and is often associated with an increased risk of cardiovascular diseases. However, few studies have shown the effects of hyperlipidemia on genomic stability. The aim of this study was to evaluate DNA damage provided by tyloxapol induced hyperlipidemia. Tyloxapol, a non-ionic surfactant, which increases the activity of the Enzyme HMG-CoA reductase and decreases clearance of lipoproteins, was used to induce hyperlipidemia in Wistar rats. Genomic instability was assessed using the comet assay which evaluates DNA strand breaks in several tissues, and the micronucleus assay in bone marrow to detect chromosomal mutagenicity for clastogenic and/or aneugenic effects. Biochemical analyses confirmed hyperlipidemia in tyloxapol-treated rats, accompanied by hyperglycemia. Higher creatinine and urea levels were observed, suggesting kidney injury. The comet assay indicated increased DNA damage in blood, liver, and kidney, but not in brain tissue. However, no increase in micronucleus frequency was observed, indicating lack of mutagenic effects. Simvastatin, used as lipid lowering drug, decreased Cholesterol and triglycerides in rats treated with tyloxapol. Those findings indicate that tyloxapol-induced hyperlipidemia is able to increase genomic instability, which is associated with higher Cancer risk. Therefore, this surfactant might be used in models to evaluate new hypolipidemic drugs with associated chemopreventive properties.

Keywords

Genotoxicity; Hyperlipidemia; Tyloxapol.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z